BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2786994)

  • 1. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.
    Breuer M; Slebos R; Verbeek S; van Lohuizen M; Wientjens E; Berns A
    Nature; 1989 Jul; 340(6228):61-3. PubMed ID: 2786994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
    Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
    Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
    Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
    Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice as a means to study synergism between oncogenes.
    Berns A; Breuer M; Verbeek S; van Lohuizen M
    Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.
    Berns A
    J Cell Biochem; 1991 Oct; 47(2):130-5. PubMed ID: 1661736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of Myb and Myc proteins in T cell lymphomagenesis.
    Davies J; Badiani P; Weston K
    Oncogene; 1999 Jun; 18(24):3643-7. PubMed ID: 10380886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
    Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
    Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
    Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
    Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
    van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
    Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
    Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
    Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
    Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
    EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
    Suchman EL; Pattengale PK; Fan H
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
    Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
    Feldman BJ; Reid TR; Cleary ML
    Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
    Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylhydrazine stimulates lymphopoiesis and accelerates Abelson murine leukemia virus-induced pre-B cell lymphomas.
    Klinken SP; Holmes KL; Fredrickson TN; Erner SM; Morse HC
    J Immunol; 1987 Nov; 139(9):3091-8. PubMed ID: 2822804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.
    Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A
    Oncogene; 1999 Oct; 18(44):5982-90. PubMed ID: 10557087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.